Hugues Barletta
Centre Léon Bérard(FR)AlterSanté(FR)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Monoclonal and Polyclonal Antibodies Research, Peptidase Inhibition and Analysis
Most-Cited Works
- → Sub-Urethral Tape Treatment of Female Urinary Incontinence?Morbidity Assessment of the Trans-Obturator Route and a New Tape (I-STOP): A Multi-Centre Experiment Involving 604 Cases(2004)86 cited
- → Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients(2017)46 cited
- → Economic Impact of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in France(2015)29 cited
- → Real-World Experience of Bevacizumab as First-Line Treatment for Ovarian Cancer: The GINECO ENCOURAGE Cohort of 468 French Patients(2021)11 cited
- → Evolution in the real-world therapeutic strategies in more than 20,000 women with breast cancer having received human epidermal growth factor receptor 2–targeted treatments: Results from the french personalized reimbursement model database (2011–2018)(2020)8 cited
- → Topotecan (T) and cyclophosphamide (CY) in second line treatment of advanced ovarian cancer (AOC): a gineco phase II trial(2001)3 cited
- [Adjuvant therapy for breast cancer patients: treatment decision tree from a French cancer network].(2002)
- → Use of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC)/ The GINECO ENCOURAGE cohort of 500 French patients(2019)2 cited
- → The Personalised Reimbursement Models (Prm): Real World Data Collection to Provide Innovative Pricing Solutions in France(2017)1 cited
- → Impact of multidisciplinary tumour board in the management of ovarian carcinoma in the first‐line setting. Exhaustive analysis from the Rhone‐Alpes region(2020)